$270,000 Drug. One Competitor. Billion-Dollar Market.
Phase 3 trial targets recurrent pericarditis with an oral therapy that could disrupt the only approved treatment. And their heart failure program launches in 2026.
Shares Stats
| Shares Outstanding | 3,159,200,000 |
| Shares Float | 3,159,200,000 |
| Shares Short | 10,640,000 |
| Insider Holdings | 1% |
| Institution Holdings | 2.72% |
About Takeda Pharmaceutical Co ADR
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.
General
| Name | Takeda Pharmaceutical Co ADR |
| Ticker | TAK |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Currency | USD |
| Country | USA |
| Fiscal Year End | March |
| Full Time Employees | 47,455 |
Highlights
| Analyst Target | 15.99 |
| Market Cap | 45,192,400,000 |
| PE Ratio | 181.54 |
| PEG Ratio | 0.30 |
| EBITDA | 1,138,373,033,984 |
Financials
| Profit Margin | 0.87% |
| Operating Margin | 11.06 |
| Return on Assets | 0.02 |
| Return on Equity | 0.00 |
| Revenue | 29.6B |
| Earnings Per Share | 0.07 |
| Revenue Per Share | 1,400.91 |
| Gross Profit | 2,862,113,882,112 |
| Quarterly Revenue Growth | -0.05 |
Valuation
| Trailing PE | 206.57 |
| Forward PE | 9.58 |
| Price/Sales (Trailing 12 Mt.) | 0.01 |
| Price/Book (Most Recent Quarter) | 1.00 |
Dividend
Takeda Pharmaceutical Co ADR pays out a dividend of $0.65 per share, with a dividend yield of 4.56%.
TAK's last dividend payment was made to shareholders on July 7, 2025.
They pay out 242.25% of their earnings out as a dividend.
Recent Dividends
| Dec 31, 1969 | $0.32 |
| Jul 7, 2025 | $0.34 |
| Dec 12, 2024 | $0.33 |
| Jul 8, 2024 | $0.30 |
December Social Security Payments Might Come Early — But There's a Catch
The Social Security Administration is altering its payment schedule for December.
16 Stocks To Buy If You Want To Escape The AI Hype
Bank of America is pointing investors toward 16 overlooked stocks with strong fundamentals and no direct ties to the AI boom—offering a safer path beyond the hype.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
OpenAI CEO Sam Altman declares 'code red' to improve ChatGPT amid rising competition in AI chatbots
SAN FRANCISCO (AP) — OpenAI CEO Sam Altman has set off a “code red” alert to employees to improve its flagship product, ChatGPT, and delay other product developments, according to The Wall Street Journal.
Here's How Americans Spent a Record $18 Billion Chasing Thanksgiving Week Deals
American consumers have demonstrated their purchasing power this Black Friday.
Bitcoin Income Crushes Dividend Stocks - Ad
Why tie up $400,000 in Pepsi for a $1,200 a month payout when one little-known Bitcoin fund can deliver the same with just $30,000?
Cathie Wood Dumps $11.6 Million Worth Of Tesla Stock: Here Is What Ark Purchased Instead
On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Tesla Inc. (NASDAQ:TSLA), Coinbase Global Inc.
Here's why everyone's talking about a 'K-shaped' economy
WASHINGTON (AP) — From corporate executives to Wall Street analysts to Federal Reserve officials, references to the “K-shaped economy” are rapidly proliferating.
Legally "Skim" $6,361 Into Your Account? - Ad
A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.
Noem Says National Guard Shooting Suspect Was Radicalized In US
DHS Secretary Kristi Noem says that the suspect in the fatal shooting of a National Guard member in Washington was radicalized domestically.
Will Santa Claus Rally Fail? Wall Street Divided Amid Mounting Volatility, Bearish Options Activity
Analysts offered mixed signals on the S&P 500's near-term outlook making a Santa rally uncertain, pointing to potential volatility, amid atypical seasonality and rising bearish options sentiment.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
US air travelers without REAL IDs will be charged a $45 fee
Air travelers in the U.S. without a will be charged a $45 fee beginning in February, the Transportation Security Administration announced Monday.
Lawsuit challenges TSA's ban on transgender officers conducting pat-downs
A Virginia transportation security officer is accusing the U.S. Department of Homeland Security of sex discrimination over a policy that bars transgender officers from performing security screening pat-downs, according to a federal lawsuit.
Trump's Crypto Law Just Created a Massive Opportunity - Ad
Trump's newly signed GENIUS Act gives crypto its first official federal framework. While attention stays on Bitcoin, one overlooked coin could benefit the most-backed by skyrocketing volume, early fund activity, and pro-crypto policy momentum.
New York advances casinos at a Bronx golf course and near Mets stadium
NEW YORK (AP) — Casinos proposed for a golf course in the Bronx and next to the New York Mets’ ballpark are poised to cash in on a for the New York City area.
Joan Branson, wife of British billionaire Richard Branson, dies at 80
Joan Branson, the wife of British billionaire Richard Branson, has died at age 80.
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
Donald Trump Administration's Unprecedented Investment In Private Firms Raises Eyebrows
President Trump administration has invested over $10 billion of taxpayer funds in private companies deemed crucial to national security.
Trump-Pardoned Ponzi Schemer Faces 37-Year Sentence For $44 Million COVID Scam
A previously convicted Ponzi schemer who had received a pardon from President Trump is heading back to prison due to involvement in a new fraudulent scheme.
The Next Biggest Bull Run In Over 50 Years - Ad
Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.
Barrick's Breakup Rumors, North America Versus The World
Barrick Mining (NYSE: B) may split into two companies, one focused on North America and another on Africa and Asia.
FDA's Prasad Cites Alleged Child COVID Shot Deaths in Push for Stricter Rules
FDA's new vaccine strategy tightens approval rules after internal findings linked COVID-19 shots to several child deaths.
Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad
AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.
In Trump-dominated media world, editing video takes on new significance — as BBC uproar shows
In the space of a few months, one of the more straightforward journalistic tasks — editing tape for broadcast — has been behind a $16 million legal settlement, a network's change in how it offers interviews on a news show and, now, the resignation of two top leaders at the BBC.
Silver Soars To Record Highs: It's Up 95% In 2025, The Best Year Since 1979
Silver prices surge over 5% as investors rush to secure metal amid tight supplies and global shortage concerns, driving up stocks and mining equities.
The Smart Money Copper Trade - Ad
Only one lines up grade, scale potential, and Quebec power like this. Insider alignment is real. Stepouts are opening new zones. With EVs and grid buildouts rising, this could be the timely copper idea you have been waiting for.
Iran confirms seizure of oil tanker in the Strait of Hormuz
TEHRAN, Iran (AP) — Iran on Saturday confirmed as it traveled through the narrow Strait of Hormuz over violations including carrying an illegal consignment, state media reported.
Elon Musk Doubles Down On Solar-Powered AI Satellites, Predicts 'Convergence' Between Tesla, SpaceX, xAI — 'Tesla Is The World Leader In…'
Elon Musk shares plans for solar-powered AI satellites in orbit, touts Tesla as world leader and targets Optimus scale production next year.
$270,000 Drug. One Competitor. Billion-Dollar Market. - Ad
Phase 3 trial targets recurrent pericarditis with an oral therapy that could disrupt the only approved treatment. And their heart failure program launches in 2026.
Elizabeth Warren Calls Trump 'Most Corrupt President' Citing Memecoin, Multi-Million CEO Dinners And Tax Cuts For Billionaires
Sen. Elizabeth Warren (D-Mass.) on Sunday called President Donald Trump’s tenure the “most corrupt” in America’s history, criticizing his involvement in cryptocurrency ventures, meetings with leading industry figures, and other decisions.
Movie Review: Time has outrun this 'Running Man'
It’s always interesting when time overtakes the dystopias of the past. In 1982 novel “The Running Man,” the United States has fallen into a totalitarian state, divided between haves and have-nots, where all movements can be surveilled and realistic video propaganda is easily generated. King’s book was set in the year 2025.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
(Micro)Strategy's Structural Reset: Why Markets Are Repricing MSTR Beyond Bitcoin
The recent decline in Strategy's (NASDAQ:MSTR) stock price is not a simple pullback, nor is it a reaction driven by short-term sentiment. What is unfolding around MSTR is a broad structural repricing.
Swiss voters reject mandatory national service for women and new inheritance tax
GENEVA (AP) — Swiss voters on Sunday decisively rejected a call to require women to do national service in the military, civil protection teams or other forms, as all men must do already.
Bitcoin Income Crushes Dividend Stocks - Ad
Why tie up $400,000 in Pepsi for a $1,200 a month payout when one little-known Bitcoin fund can deliver the same with just $30,000?
Rand Paul Slams GOP's Shift From Fiscal Conservatism: They Voted To Add '$5 Trillion' To The Debt Ceiling — Calls It 'Decimation'
Sen. Rand Paul (R-Ky.) slammed the Republican Party for abandoning the fiscal discipline it once championed, while accusing his colleagues of embracing massive governmental deficits and greenlighting spending levels they previously opposed.
All 14 victims identified from fiery UPS cargo plane crash in Louisville
LOUISVILLE, Ky. (AP) — A grandfather and his young granddaughter. An electrician with two young children. A woman standing in line at a scrap metal business.
Legally "Skim" $6,361 Into Your Account? - Ad
A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.
Weekend Round-Up: TSMC Trade Secrets Lawsuit, Google Deepmind Scientist's Market Slam, Baidu Layoffs, Amazon's Court Victory And More
From allegations of trade secret leaks at Taiwan's TSMC to layoffs at Baidu Inc, here's a recap of tech news this week.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.